Health

Add as a preferred source on Google

U.S. Review Finds 112 Measles Infections in Pregnancy, 13 Congenital Cases

The preliminary analysis recorded 26 hospital admissions and eight premature births among 19 live births within 14 days after mothers’ rash onset.

Updated 2 min read
Staff members enter the Centers for Disease Control and Prevention campus in Atlanta, Georgia. (AI-generated image / EconoTimes)
Staff members enter the Centers for Disease Control and Prevention campus in Atlanta, Georgia. (AI-generated image / EconoTimes)

An analysis published Nov. 16 counted 112 confirmed measles infections in pregnant women and 13 congenital measles cases in infants in the United States, with complications documented among mothers and newborns.

The preliminary analysis in NEJM Evidence covers reports to the Centers for Disease Control and Prevention (CDC) from 16 U.S. jurisdictions between Jan. 1, 2025, and Sept. 28, 2026. Researchers said most cases were linked to large outbreaks.

The review recorded 26 hospital admissions for reasons unrelated to labor, equal to 23% of the pregnant women, and 11 cases of pneumonia. The report’s 13 congenital cases were infants who met its definition of congenital measles.

Among 19 live births within 14 days after their mothers’ rash onset, eight were premature and eight infants were admitted to neonatal intensive care. Researchers also recorded two pregnancy losses within that 14-day period: one miscarriage and one stillbirth. The report listed 21 outcomes during the period, including those 19 live births and two losses.

Outcome information was available for 37 pregnancies. Nineteen were presumed to be ongoing, while the outcome was unknown for 56.

Of the 112 women, 110 had not received a measles, mumps and rubella (MMR) vaccine before pregnancy or had an unknown vaccination status. The report says MMR vaccination is not recommended during pregnancy and cites CDC guidance advising intravenous immunoglobulin after exposure for pregnant women without documented vaccination or other evidence of immunity.

The authors described the findings as preliminary, said data collection is continuing and called for longer-term tracking of mothers and infants. EconoTimes previously covered Pennsylvania’s guidance for clinicians treating pregnant patients and newborns.

Related articles

View all